ArticleJournal of clinical medicine2025

Eight Years of Follow-Up of Rituximab in Pemphigus Vulgaris and Foliaceus at a Single Center: Assessing Efficacy and Safety in Light of Several Factors.

Konrad Szymanski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.